Life Biosciences plans to begin human clinical trials of a cellular rejuvenation therapy in optic neuropathies after ...
BOSTON, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, ...
GlobalData on MSN
Life Bio receives FDA approval for ER-100 clinical trial
The Phase I trial will recruit participants who have been diagnosed with non-arteritic anterior ischaemic optic neuropathy and open-angle glaucoma.
Phase 1b clinical site start-up and regulatory activities in Australia underway to support the global registrational program -HUNTSVILLE, AL, ...
The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, enabling the initiation of the EYETAC phase II clinical trial ( NCT07285070) in ...
MicuRx Pharmaceuticals, Inc. (MicuRx), a clinical-stage biopharmaceutical company focused on developing novel anti-infective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results